KIT ESTÉRIL PARA ADMINISTRACIÓN DE BEVACIZUMAB

Resultado y ofertas (1)

1oferente

Adjudicada a

Proveedor	Producto / línea	Precio unit.	Total ofertado	Adjudicado	Estado
OFTOMED S.A.78.075.900-3	DACLIZUMAB1.200 Unidad·1 oferente	$28.520	$34.224.000	$34.224.000	Adjudicada

Resultado y ofertas

Gratis con tu RUT

Regístrate gratis y te decimos tu probabilidad de ganar este tipo de licitación, si tu empresa ya compitió por estos productos y contra quién.

Órdenes de compra (24)

Total comprado

$25.623.794

Código OC	Proveedor	Envío	Total
4817-1789-SE26	OFTOMED S.A.78.075.900-3	22-05-2026	$2.036.328
4817-567-SE26	OFTOMED S.A.78.075.900-3	04-02-2026	$1.357.552
4817-450-SE26	OFTOMED S.A.78.075.900-3	02-02-2026	$1.357.552
4817-3869-SE25	OFTOMED S.A.78.075.900-3	26-08-2025	$339.388
4817-3913-SE25	OFTOMED S.A.78.075.900-3	02-09-2025	$1.018.164
4817-341-SE26	OFTOMED S.A.78.075.900-3	14-01-2026	$271.510
4817-92-SE26	OFTOMED S.A.78.075.900-3	08-01-2026	$1.696.940
4817-3391-SE25	OFTOMED S.A.78.075.900-3	08-07-2025	$1.018.164
4817-2710-SE25	OFTOMED S.A.78.075.900-3	29-04-2025	$678.776
4817-3143-SE25	OFTOMED S.A.78.075.900-3	16-06-2025	$1.018.164
4817-2903-SE25	OFTOMED S.A.78.075.900-3	19-05-2025	$1.018.164
4817-2467-SE25	OFTOMED S.A.78.075.900-3	31-03-2025	$678.776
4817-4893-SE25	OFTOMED S.A.78.075.900-3	26-11-2025	$339.388
4817-6965-SE25	OFTOMED S.A.78.075.900-3	22-12-2025	$1.086.042
4817-4605-SE25	OFTOMED S.A.78.075.900-3	18-11-2025	$509.082
4817-5051-SE25	OFTOMED S.A.78.075.900-3	16-12-2025	$339.388
4817-4425-SE25	OFTOMED S.A.78.075.900-3	07-10-2025	$1.018.164
4817-434-SE25	OFTOMED S.A.78.075.900-3	27-02-2025	$1.018.164
4817-1828-SE24	OFTOMED S.A.78.075.900-3	16-08-2024	$1.696.940
4817-1669-SE24	OFTOMED S.A.78.075.900-3	30-07-2024	$1.696.940
4817-100-SE25	OFTOMED S.A.78.075.900-3	14-01-2025	$1.018.164
4817-8-SE25	OFTOMED S.A.78.075.900-3	04-01-2025	$1.018.164
4817-2190-SE24	OFTOMED S.A.78.075.900-3	08-10-2024	$1.696.940
4817-2345-SE24	OFTOMED S.A.78.075.900-3	07-11-2024	$1.696.940